PainReform Ltd. (PRFX) vs China SXT Pharmaceuticals, Inc. (SXTC)
- PainReform Ltd. PRFX 0.81 −4.71%
- China SXT Pharmaceuticals, Inc. SXTC 0.07 0.00%
PainReform Ltd. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $2.6M against $710.0K — 3.6× the size. PainReform Ltd. has the higher net margin (0.00% vs −255.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, PainReform Ltd. leads on 5 and China SXT Pharmaceuticals, Inc. on 4.
Valuation
| Metric | PRFX | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | n/m | n/m | 2.11 |
| P/B | 0.00 | n/m | 1.78 |
| Price to free cash flow | n/m | n/m | 16.14 |
| EV/EBITDA | 0.97 | 2.66 | 12.58 |
| EV/Sales | n/m | (5.94) | 2.73 |
| Earnings yield | (73,121.23%) | (159,014.29%) | (4.38%) |
| Free cash flow yield | (95,565.78%) | 0.00% | 0.00% |
Profitability
| Metric | PRFX | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 36.69% | 53.94% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | (255.16%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 0.00% | (0.40%) |
| Return on assets | 0.00% | 0.00% | (3.32%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack